On Monday, Following Stocks were among the “Top 100 Gainers” In U.S. Stock Exchange: IAMGOLD Corp (USA) (NYSE:IAG), Advaxis, Inc (NASDAQ:ADXS), Callon Petroleum Company (NYSE:CPE), Tiffany & Co (NYSE:TIF)
IAMGOLD Corp (USA) (NYSE:IAG)’s shares picked up 5.91%, and closed at $2.15. The stock volatility for the week is 4.17M%, while for the month remained 6.93M%. The company holds consensus target price of $3.03.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.72 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 68.60% and Annual EPS growth for the past 5 years is considered as -42.10%.
The mean recommendation of analysts for this stock is 3.30. (where 1=Buy, 5=Sale).
IAMGOLD Corporation explores, develops, and operates gold mining properties. The company also explores for silver, niobium, and copper deposits. It holds interests in four operating gold mines, in addition to exploration and development projects located in Africa, South America, and Canada. The company was incorporated in 1990 and is headquartered in Toronto, Canada.
Advaxis, Inc (NASDAQ:ADXS), raised 5.90%, and closed at $13.28. The stock has price to sale ratio of 361.35, however, price to book ratio is 9.10. With recent incline, the year-to-date (YTD) performance reflected a 65.79% gain below last year. During the past month the stocks lose 61.56%, bringing three-month performance to 173.25% and six-month performance to 318.93%. The mean recommendation of analysts for this stock is 2.00. (where 1=Buy, 5=Sale).
Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. The Lm-LLO immunotherapy platform technology stimulates the immune system to induce antigen-specific anti-tumor immune responses involving innate and adaptive arms of the immune system by inhibiting the T-cells, tregs, and myeloid-derived suppressor cells, and MDSC to promote immunologic tolerance of cancer cells in the tumor. Its lead product ADXS-HPV, an Lm-LLO immunotherapy product candidate used for the treatment of human papilloma virus (HPV) associated cancers, accomplished its Phase II study.
Callon Petroleum Company (NYSE:CPE), enhanced 5.81%, and closed at $7.29. The company holds the market capitalization of $454.27M. For the last twelve months, the stock was able to keep return on equity at 8.40%, while return on assets at 4.80%, in response to its return on investment at 2.00%. Its 20-day moving average gained 4.12%, above 50-day moving average of 12.85%, above 200-day moving average of -7.12% from the latest market price of $7.29. The mean recommendation of analysts for this stock is 2.10.(where 1=Buy, 5=Sale).
Callon Petroleum Company engages in the exploration, development, attainment, and production of oil and natural gas properties in the Permian Basin in West Texas. As of December 31, 2014, its estimated net proved reserves totaled 32.8 million barrel of oil equivalent, counting 25.7 million barrels of oil and 42.5 billion cubic feet of natural gas. The company was founded in 1950 and is headquartered in Natchez, Mississippi.
Tiffany & Co (NYSE:TIF), rose 5.80%, and closed at $87.74, hitting new 52-week low of $82.64. The stock has the beta value of 1.81, and its volatility for the week is 3.32%, while for the month it is 2.35%. The company has the market capitalization of $11.35B. The company holds the book value per share of 22.04, whereas cash per share is 5.66. Price to book ratio remained 3.98, while price to sale ratio is 2.67. Analysts mean recommendation for the stock is said to be 2.30 (where 1=Buy, 5=sale).
Tiffany & Co., through its subsidiaries, designs, manufactures, and retails jewelry worldwide. The company operates through Americas, Asia-Pacific, Japan, Europe, and Other segments. Its jewelry products comprise fine and solitaire jewelry; engagement rings and wedding bands to brides and grooms; and non-gemstone, sterling silver, gold, and metal jewelry. The company also sells timepieces, leather goods, sterling silverware, china, crystal, stationery, fragrances, and accessories. Tiffany & Co. sells its products through retail sales, Internet and catalog sales, business-to-business sales, and wholesale distribution. As of April 30, 2014, it operated 292 stores, counting 121 stores in the Americas, 72 stores in the Asia-Pacific, 55 stores in Japan, 38 stores in Europe, 5 stores in the United Arab Emirates, and 1 store in Russia. The company was founded in 1837 and is headquartered in New York, New York.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
